Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
National Institutes of Health · PAR-25-282 · Research funding opportunity
Overview
Supports exploratory translational research into mood and psychotic symptoms during the menopause transition. Projects should examine underlying mechanisms and identify promising targets for future intervention development.
Funding amount
Up to USD 275000 in direct costs over 2 years; maximum USD 200000 per year
Eligibility
Wits may apply as a non-US higher education institution. Proposals must fit this call and the mission of a participating institute; institutional registrations and funder requirements apply.
Other deadlines
Next new-application deadline: 16 October 2026. Next renewal/resubmission/revision deadline, where permitted: 16 November 2026. Submit by 17:00 local time of the applicant organisation. Call expiration: 8 January 2028. This is separate from the application deadline.